# Cellectar Biosciences, Inc.: filings

CLRB · Nasdaq · CIK 1279704 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/clrb.md) · [Financials](/companies/clrb/financials.md) · [Filings](/companies/clrb/filings.md) · [Insiders](/companies/clrb/insiders.md)

## Reports and events: 530 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 381, 4 175, 424B3 62, 10-Q 53, CORRESP 41, SC 13G/A 37, UPLOAD 33, EFFECT 31, 3 29, SC 13G 28, S-1/A 23, S-1 19, 10-K 18, DEF 14A 18, PRE 14A 15, SCHEDULE 13G 11, SCHEDULE 13G/A 11, DEFA14A 10, 10-K/A 9, 424B5 9, D 8, S-3 8, POS AM 7, 424B4 6, FWP 5, S-8 5, 424B1 4, 4/A 4, NT 10-Q 4, 8-K/A 3, ARS 3, S-3/A 3, 10-Q/A 2, 25-NSE 2, 3/A 2, 8-A12B 2, CERTNAS 2, DEFR14A 2, PRER14A 2, S-1MEF 2, SC 13D 2, SC 13D/A 2, 5 1, CT ORDER 1, D/A 1, DRS 1, NT 10-K 1, RW 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-13 | 07:25 ET | [8-K](/filings/0001104659-26-095460.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-095460 |
| 2026-08-13 | 07:00 ET | [10-Q](/filings/0001104659-26-095426.md) | Quarterly report, period 2026-06-30 | 0001104659-26-095426 |
| 2026-07-10 | 17:13 ET | [8-K](/filings/0001104659-26-082719.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-082719 |
| 2026-05-29 | 08:50 ET | [S-1/A](/filings/0001104659-26-067933.md) | Registration statement, amended | 0001104659-26-067933 |
| 2026-05-28 | 17:13 ET | [DEF 14A](/filings/0001104659-26-067626.md) | Proxy statement, period 2026-07-07 | 0001104659-26-067626 |
| 2026-05-19 | 17:05 ET | [S-1](/filings/0001104659-26-063918.md) | Registration statement | 0001104659-26-063918 |
| 2026-05-18 | 16:15 ET | [8-K](/filings/0001104659-26-063202.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-063202 |
| 2026-05-14 | 07:20 ET | [8-K](/filings/0001104659-26-060693.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-060693 |
| 2026-05-14 | 07:00 ET | [10-Q](/filings/0001104659-26-060678.md) | Quarterly report, period 2026-03-31 | 0001104659-26-060678 |
| 2026-05-08 | 06:04 ET | [8-K](/filings/0001104659-26-057460.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-057460 |
| 2026-04-30 | 16:51 ET | [10-K/A](/filings/0001104659-26-053090.md) | Annual report, amended, period 2025-12-31 | 0001104659-26-053090 |
| 2026-03-04 | 07:23 ET | [8-K](/filings/0001104659-26-023169.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-023169 |
| 2026-03-04 | 07:21 ET | [10-K](/filings/0001104659-26-023167.md) | Annual report, period 2025-12-31 | 0001104659-26-023167 |
| 2025-11-13 | 07:30 ET | [8-K](/filings/0001104659-25-110848.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-110848 |
| 2025-11-13 | 07:00 ET | [10-Q](/filings/0001104659-25-110827.md) | Quarterly report, period 2025-09-30 | 0001104659-25-110827 |
| 2025-10-20 | 16:31 ET | [S-1](/filings/0001104659-25-100854.md) | Registration statement | 0001104659-25-100854 |
| 2025-10-10 | 16:30 ET | [8-K](/filings/0001104659-25-098725.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-098725 |
| 2025-10-06 | 07:15 ET | [8-K](/filings/0001104659-25-096928.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-096928 |
| 2025-08-14 | 07:30 ET | [8-K](/filings/0001104659-25-078102.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-078102 |
| 2025-08-14 | 07:07 ET | [10-Q](/filings/0001410578-25-001778.md) | Quarterly report, period 2025-06-30 | 0001410578-25-001778 |
| 2025-06-30 | 08:29 ET | [S-1/A](/filings/0001104659-25-063849.md) | Registration statement, amended | 0001104659-25-063849 |
| 2025-06-26 | 09:26 ET | [8-K](/filings/0001104659-25-062837.md) | 8.01 Other events | 0001104659-25-062837 |
| 2025-06-26 | 09:22 ET | [S-1](/filings/0001104659-25-062834.md) | Registration statement | 0001104659-25-062834 |
| 2025-06-25 | 17:22 ET | [8-K](/filings/0001104659-25-062639.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-25-062639 |
| 2025-06-18 | 16:45 ET | [8-K](/filings/0001104659-25-060661.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-060661 |
| 2025-06-13 | 16:30 ET | [8-K](/filings/0001104659-25-059400.md) | 5.07 Shareholder vote results | 0001104659-25-059400 |
| 2025-06-05 | 09:26 ET | [8-K](/filings/0001104659-25-056697.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-056697 |
| 2025-05-13 | 07:15 ET | [8-K](/filings/0001104659-25-047568.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-047568 |
| 2025-05-13 | 07:02 ET | [10-Q](/filings/0001410578-25-001205.md) | Quarterly report, period 2025-03-31 | 0001410578-25-001205 |
| 2025-05-01 | 06:04 ET | [8-K](/filings/0001104659-25-042870.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-042870 |
| 2025-04-28 | 16:31 ET | [DEF 14A](/filings/0001104659-25-040241.md) | Proxy statement, period 2025-06-13 | 0001104659-25-040241 |
| 2025-03-17 | 16:30 ET | [8-K](/filings/0001104659-25-024446.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-25-024446 |
| 2025-03-13 | 07:15 ET | [8-K](/filings/0001104659-25-023216.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-023216 |
| 2025-03-13 | 06:50 ET | [10-K](/filings/0001410578-25-000329.md) | Annual report, period 2024-12-31 | 0001410578-25-000329 |
| 2025-01-31 | 16:30 ET | [8-K](/filings/0001104659-25-008127.md) | 3.01 Delisting notice | 0001104659-25-008127 |
| 2025-01-29 | 16:16 ET | [S-1](/filings/0001410578-25-000060.md) | Registration statement | 0001410578-25-000060 |
| 2025-01-14 | 06:01 ET | [8-K](/filings/0001104659-25-003208.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-003208 |
| 2024-12-11 | 09:05 ET | [8-K](/filings/0001104659-24-127487.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-127487 |
| 2024-11-18 | 07:15 ET | [8-K](/filings/0001104659-24-119941.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-119941 |
| 2024-11-18 | 06:46 ET | [10-Q](/filings/0001410578-24-002012.md) | Quarterly report, period 2024-09-30 | 0001410578-24-002012 |
| 2024-11-15 | 16:33 ET | [8-K](/filings/0001104659-24-119738.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-119738 |
| 2024-11-01 | 17:15 ET | [8-K](/filings/0001104659-24-113549.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-113549 |
| 2024-10-29 | 17:09 ET | [10-Q](/filings/0001410578-24-001708.md) | Quarterly report, period 2024-06-30 | 0001410578-24-001708 |
| 2024-10-29 | 17:03 ET | [10-Q/A](/filings/0001410578-24-001706.md) | Quarterly report, amended, period 2024-03-31 | 0001410578-24-001706 |
| 2024-10-29 | 16:56 ET | [10-K/A](/filings/0001410578-24-001704.md) | Annual report, amended, period 2023-12-31 | 0001410578-24-001704 |
| 2024-08-23 | 17:15 ET | [8-K](/filings/0001104659-24-092495.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-092495 |
| 2024-08-13 | 06:45 ET | [8-K](/filings/0001104659-24-088606.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-088606 |
| 2024-08-09 | 17:00 ET | [8-K](/filings/0001104659-24-087859.md) | 4.02 Non-reliance on financial statements | 0001104659-24-087859 |
| 2024-07-23 | 06:45 ET | [8-K](/filings/0001104659-24-081680.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-081680 |
| 2024-07-22 | 06:45 ET | [8-K](/filings/0001104659-24-081307.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-081307 |

Page 1 of 11. [Older](/companies/clrb/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.